Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.

International journal of oncology

Volumn 22, Issue 5, 2003, Pages 1117-1121

  Kafka, Ariane ^a   Sauer, Georg ^a   Jaeger, Christoph ^a   Grundmann, Regina ^a   Kreienberg, Rolf ^a   Zeillinger, Robert ^a   Deissler, Helmut ^a  

^a UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIGOXIN; ESTROGEN RECEPTOR; GLYCOPROTEIN P; PROGESTERONE RECEPTOR; PROTEIN P53;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BIOAVAILABILITY; BREAST TUMOR; EXON; FEMALE; GENE; GENETICS; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MENOPAUSE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PREDICTION AND FORECASTING; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL AVAILABILITY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DIGOXIN; EXONS; FEMALE; GENES, MDR; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0041627670     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.22.5.1117     Document Type: Article

References (0)